Lexogen.com Website Review

tag individual transcripts to identify and correct pcr bias.. lexogen is a biotech company focusing on rna and complete transcriptome studies using next generation sequencing technologies. we have been at the forefront of rna research since 2007, and our technologies and products are being used by thousands of scientists all over the world. “lexo” in greek means “word”, and lexogen stands for the word of genes, which is the transcriptome. we strive to be the pioneers in this fascinating field of rna science, and together with the fastest-growing technology of the past years, the next generation sequencing (ngs), we are sure that we can make a big contribution to the world. protocol for generation of small rna libraries for illumina sequencing directly from total rna or enriched small rna. of ribosomal rna from total rna and is suited for next generation sequencing as well as other demanding rna an*lysis applications. workflows and to control individual samples pas*ing through rna-seq experiments. they are available in 3 sets. non-isoform ercc transcripts provides controls for examining isoform resolution and dynamic range resolution. available for illumina and ion torrent sequencing platforms. an automated sense mrna-seq library prep quantseq kits enable cost-efficient sequencing by counting. these kits are an exceptional alternative to standard rna-seq and microarrays. just one fragment per transcript is produced and therefore there is no need for length normalization. this makes data an*lysis very simple and accurate. up to 384 samples can be multiplexed in one lane, saving your sequencing space. quantseq is available for 3’ mrna-seq and solution for genome-wide gene expression an*lysis by sequencing towards the poly(a) tail. the kit is available for illumina is designed in a way that ngs reads start directly at the 3’ end of transcripts, enabling detailed 3’ utr an*lysis and the study of designed to make illumina compatible libraries from any rna sample using custom primers. it is open for development by advanced rna-seq